DuPont acquires Dyadic's C1 enzyme technology for $75 million

Earlier this week Dyadic announced DuPont will acquire its C1 industrial enzyme technology platform for $75 million. While the deal transfers nearly all of Dyadic's industrial enzyme technology assets to DuPont, the announcement also disclosed that Dyadic will continue to have co-exclusive rights to...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research

Kerry strengthens its cell-free offerings by acquisition of c-LEcta

News Commentary | February 17, 2022

Irish ingredients player Kerry has recently agreed to acquire a 92% stake in German company c‑LEcta, which develops enzymes and provides protein engineering services. The deal amounts to EUR 137 million. Through this acquisition, Kerry is looking to strengthen its existing enzymes portfolio ... Not part of subscription

Yali Bio raises USD 3.9 million for fats through precision fermentation

News Commentary | March 23, 2022

Yali Bio announced a USD 3.9 million seed round led by Essential Capital, Third Kind VC, and S2G Ventures. This brings its total funding to USD 5 million. The funding will be used to continue its R&D process and test its animal‑like fat solutions. It hopes to have prototype products by spring or... Not part of subscription

Whitefox Technologies

Company Profile | April 26, 2022

Developed modified hollow fiber polyimide and polybenzimidazole (PBI) membrane cartridges that can withstand high temperature and pressure and offer low fouling in vapor separations Utilizes integrated cartridge efficiency (ICE) units to house the membranes for dehydration of alcohols and ... Not part of subscription